Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis

International Urology and Nephrology

Volumn 42, Issue 2, 2010, Pages 393-399

  Kutlu, Omer ^a   Akkaya, Erdem ^a   Koksal, Ismail Turker ^a   Bassorgun, Ibrahim Cumhur ^a   Ciftcioglu, Mehmet Akif ^a   Sanlioglu, Salih ^a   Kukul, Erdal ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Interstitial cystitis; Pathogenesis; TRAIL

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3;

ARTICLE; BLADDER BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CYSTITIS; MALE; MOLECULAR WEIGHT; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

BIOPSY; CYSTITIS, INTERSTITIAL; HUMANS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND; URINARY BLADDER;

EID: 77956188289     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9632-z     Document Type: Article

References (47)

1. Hanno PM, Landis JR, Matthews-Cook Y et al (1999) The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 161(2):553-557
2. Oravisto KJ (1975) Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn 64:75-77
3. Curhan GC, Speizer FE, Hunter DJ (1999) Epidemiology of interstitial cystitis: a population based study. J Urol 161(2):549-552
4. Leppilahti M, Tammela TL, Huhtala H et al (2002) Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol 168(1):139-143
5. O'Leary MP, Sant GR, Fowler FJ Jr et al (1997) The interstitial cystitis symptom index and problem index. Urology 49(5A):58-63
6. Shea-O'Malley CC, Sant GR (1999) Quality of life in interstitial cystitis. Urol Intregrada Invest 4:303-306
7. Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145(4): 732-735
8. Parsons CL, Stein PC, Bidair M et al (1994) Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13(5):515-520
9. Parsons CL, Forrest J, Nickel JC et al (2002) Elmiron Study Group. Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 59(3):329-333
10. Lewis SA, Diamond JM (1976) Na+ transport by rabbit urinary bladder, a tight epithelium. J Membr Biol 28(1): 1-40
11. Eldrup J, Thorup J, Nielsen SL et al (1983) Permeability and ultrastructure of human bladder epithelium. Br J Urol 55(5):488-492
12. Trelstad RL (1985) Glycosaminoglycans: mortar, matrix, mentor. Lab Invest 53:l-l4
13. Cornish J, Nickel JC, Vanderwee M et al (1990) Ultrastructural visualization of human bladder mucous. Urol Res 18:263-264
14. Ruoslahti E (1988) Structure and biology of proteoglycans. Annu Rev Cell Biol 4:229-232
15. Gill WB, Jones KW, Ruggiero KJ (1982) Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured urothelium. J Urol 127(1):152-154
16. Parsons CL, Mulholland SG, Anwar H (1979) Antibacterial activity of bladder surface mucin duplicated by exogenous glycosaminoglycan (heparin). Infect Immun 24(2):552-557
17. Hohlbrugger G (1995) The vesical blood-urine barrier: a relevant and dynamic interface between renal function and nervous bladder control. J Urol 154(1):6-15
18. Hohlbrugger G, Lentsch P, Pfaller K et al (1985) Permeability characteristics of the rat urinary bladder in experimental cystitis and after overdistension. Urol Int 40(4): 211-216
19. Saban R, Keith IM, Bjorling DE (1997) Neuropeptide-mast cell interaction in interstitial cystitis. In: Sant GR (ed) Interstitial cystitis. Lippincott-Raven, Philadelphia, pp 53-66
20. Theoharides TC, Sant GR (1991) Bladder mast cell activation in interstitial cystitis. Semin Urol 9(2):74-87
21. Theoharides TC, Pang X, Letourneau R et al (1998) Interstitial cystitis: a neuroimmunoendocrine disorder. Ann NY Acad Sci 840:619-634
22. Abdel-Mageed AB, Ghoniem GM (1998) Potential role of rel/nuclear factor-kappaB in the pathogenesis of interstitial cystitis. J Urol 160(6):2000-2003
23. Nazif O, Teichman JM, Gebhart GF (2007) Neural upregulation in interstitial cystitis. Urology 69(4):24-33
24. Sadhukhan PC, Tchetgen MB, Rackley RR et al (2002) Sodium pentosan polysulfate reduces urothelial responses to inflammatory stimuli via an indirect mechanism. J Urol 168(1):289-292
25. Nesterov A, Lu X, Johnson M et al (2001) Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem 276(14): 10767-10774
26. Degli-Esposti MA, Dougall WC, Smolak PJ et al (1997) The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7(6):813-820
27. Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 6:673-682
28. Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA et al (2003) Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat Immunol 4(3):255-260
29. Wang XC, Saban R, Kaysen JH et al (2000) Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder. J Urol 163(3):993-998
30. Lynes WL, Flynn SD, Shortliffe LD et al (1987) Mast cell involvement in interstitial cystitis. J Urol 138:746-752
31. Berent-Maoz B, Piliponsky AM, Daigle I et al (2006) Human mast cells undergo TRAIL-induced apoptosis. J Immunol 176(4):2272-2278
32. Renshaw SA, Parmar JS, Singleton V et al (2003) Acceleration of human neutrophil apoptosis by TRAIL. J Immunol 170(2):1027-1033
33. Zamai L, Ahmad M, Bennett IM et al (1998) Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 188(12):2375-2380
34. Sedger LM, Glaccum MB, Schuh JC et al (2002) Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/ Apo2L gene-deficient mice. Eur J Immunol 32(8): 2246-2254
35. Ludwig AT, Moore JM, Luo Y et al (2004) Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guerin- induced antitumor activity. Cancer Res 64(10):3386-3390
36. Kimberley FC, Screaton GR (2004) Following a TRAIL: update on a ligand and its five receptors. Cell Res 14(5): 359-372
37. Hu WH, Johnson H, Shu HB (1999) Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways. J Biol Chem 274(43):30603-30610
38. Koksal IT, Sanlioglu AD, Karacay B et al (2008) Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma. Urol Oncol 26(2):158-165
39. Sanlioglu AD, Koksal IT, Ciftcioglu A et al (2007) Differential expression of TRAIL and its receptors in benign and malignant prostate tissues. J Urol 177(1):359-364
40. Griffith TS, Anderson RD, Davidson BL et al (2000) Adenoviral-mediated transfer of the TNF-related apoptosis- inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol 165(5):2886-2894
41. Takayanagi H, Juji T, Miyazaki T et al (1999) Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J Clin Invest 104(2):137-146
42. Terzioglu E, Bisgin A, Sanlioglu AD et al (2007) Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis. Rheumatology (Oxford) 46(5):783-789
43. Sanlioglu AD, Koksal IT, Karacay B et al (2006) Adenovirus- mediated IKKb expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Cancer Gene Ther 13(1):21-31
44. Franco AV, Zhang XD, Van Berkel E et al (2001) The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells. J Immunol 166(9):5337-5345
45. Lamhamedi-Cherradi SE, Zheng SJ, Tisch RM et al (2003) Critical roles of tumor necrosis factor-related apoptosisinducing ligand in type 1 diabetes. Diabetes 52:2274-2278
46. Sato K, Nakaoka T, Yamashita N et al (2005) TRAILtransduced dendritic cells protect mice from acute graftversus- host disease and leukemia relapse. J Immunol 174: 4025-4033
47. Dirice E, Sanlioglu AD, Kahraman S et al. (2009) Adenovirus mediated TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets prolongs normoglycemia in STZ-induced diabetic rats. Hum Gene Ther doi:10.1089/hum.2009.039